Cargando…

A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins

BACKGROUND: The Gag capsid (CA) is one of the most conserved proteins in highly-diversified human and simian immunodeficiency viruses (HIV and SIV). Understanding the limitations imposed on amino acid sequences in CA could provide valuable information for vaccine immunogen design or anti-HIV drug de...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Natsuko, Takeuchi, Hiroaki, Yokoyama, Masaru, Sato, Hironori, Ryo, Akihide, Yamamoto, Hiroyuki, Kawada, Miki, Matano, Tetsuro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964592/
https://www.ncbi.nlm.nih.gov/pubmed/20955553
http://dx.doi.org/10.1186/1742-4690-7-90
_version_ 1782189392931061760
author Inagaki, Natsuko
Takeuchi, Hiroaki
Yokoyama, Masaru
Sato, Hironori
Ryo, Akihide
Yamamoto, Hiroyuki
Kawada, Miki
Matano, Tetsuro
author_facet Inagaki, Natsuko
Takeuchi, Hiroaki
Yokoyama, Masaru
Sato, Hironori
Ryo, Akihide
Yamamoto, Hiroyuki
Kawada, Miki
Matano, Tetsuro
author_sort Inagaki, Natsuko
collection PubMed
description BACKGROUND: The Gag capsid (CA) is one of the most conserved proteins in highly-diversified human and simian immunodeficiency viruses (HIV and SIV). Understanding the limitations imposed on amino acid sequences in CA could provide valuable information for vaccine immunogen design or anti-HIV drug development. Here, by comparing two pathogenic SIV strains, SIVmac239 and SIVsmE543-3, we found critical amino acid residues for functional interaction between the N-terminal and the C-terminal domains in CA. RESULTS: We first examined the impact of Gag residue 205, aspartate (Gag205D) in SIVmac239 and glutamate (Gag205E) in SIVsmE543-3, on viral replication; due to this difference, Gag(206-216 )(IINEEAADWDL) epitope-specific cytotoxic T lymphocytes (CTLs) were previously shown to respond to SIVmac239 but not SIVsmE543-3 infection. A mutant SIVmac239, SIVmac239Gag205E, whose Gag205D is replaced with Gag205E showed lower replicative ability. Interestingly, however, SIVmac239Gag205E passaged in macaque T cell culture often resulted in selection of an additional mutation at Gag residue 340, a change from SIVmac239 valine (Gag340V) to SIVsmE543-3 methionine (Gag340M), with recovery of viral fitness. Structural modeling analysis suggested possible intermolecular interaction between the Gag205 residue in the N-terminal domain and Gag340 in the C-terminal in CA hexamers. The Gag205D-to-Gag205E substitution in SIVmac239 resulted in loss of in vitro core stability, which was recovered by additional Gag340V-to-Gag340M substitution. Finally, selection of Gag205E plus Gag340M mutations, but not Gag205E alone was observed in a chronically SIVmac239-infected rhesus macaque eliciting Gag(206-216)-specific CTL responses. CONCLUSIONS: These results present in vitro and in vivo evidence implicating the interaction between Gag residues 205 in CA NTD and 340 in CA CTD in SIV replication. Thus, this study indicates a structural constraint for functional interaction between SIV CA NTD and CTD, providing insight into immunogen design to limit viral escape options.
format Text
id pubmed-2964592
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29645922010-10-28 A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins Inagaki, Natsuko Takeuchi, Hiroaki Yokoyama, Masaru Sato, Hironori Ryo, Akihide Yamamoto, Hiroyuki Kawada, Miki Matano, Tetsuro Retrovirology Research BACKGROUND: The Gag capsid (CA) is one of the most conserved proteins in highly-diversified human and simian immunodeficiency viruses (HIV and SIV). Understanding the limitations imposed on amino acid sequences in CA could provide valuable information for vaccine immunogen design or anti-HIV drug development. Here, by comparing two pathogenic SIV strains, SIVmac239 and SIVsmE543-3, we found critical amino acid residues for functional interaction between the N-terminal and the C-terminal domains in CA. RESULTS: We first examined the impact of Gag residue 205, aspartate (Gag205D) in SIVmac239 and glutamate (Gag205E) in SIVsmE543-3, on viral replication; due to this difference, Gag(206-216 )(IINEEAADWDL) epitope-specific cytotoxic T lymphocytes (CTLs) were previously shown to respond to SIVmac239 but not SIVsmE543-3 infection. A mutant SIVmac239, SIVmac239Gag205E, whose Gag205D is replaced with Gag205E showed lower replicative ability. Interestingly, however, SIVmac239Gag205E passaged in macaque T cell culture often resulted in selection of an additional mutation at Gag residue 340, a change from SIVmac239 valine (Gag340V) to SIVsmE543-3 methionine (Gag340M), with recovery of viral fitness. Structural modeling analysis suggested possible intermolecular interaction between the Gag205 residue in the N-terminal domain and Gag340 in the C-terminal in CA hexamers. The Gag205D-to-Gag205E substitution in SIVmac239 resulted in loss of in vitro core stability, which was recovered by additional Gag340V-to-Gag340M substitution. Finally, selection of Gag205E plus Gag340M mutations, but not Gag205E alone was observed in a chronically SIVmac239-infected rhesus macaque eliciting Gag(206-216)-specific CTL responses. CONCLUSIONS: These results present in vitro and in vivo evidence implicating the interaction between Gag residues 205 in CA NTD and 340 in CA CTD in SIV replication. Thus, this study indicates a structural constraint for functional interaction between SIV CA NTD and CTD, providing insight into immunogen design to limit viral escape options. BioMed Central 2010-10-18 /pmc/articles/PMC2964592/ /pubmed/20955553 http://dx.doi.org/10.1186/1742-4690-7-90 Text en Copyright ©2010 Inagaki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Inagaki, Natsuko
Takeuchi, Hiroaki
Yokoyama, Masaru
Sato, Hironori
Ryo, Akihide
Yamamoto, Hiroyuki
Kawada, Miki
Matano, Tetsuro
A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins
title A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins
title_full A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins
title_fullStr A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins
title_full_unstemmed A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins
title_short A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins
title_sort structural constraint for functional interaction between n-terminal and c-terminal domains in simian immunodeficiency virus capsid proteins
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964592/
https://www.ncbi.nlm.nih.gov/pubmed/20955553
http://dx.doi.org/10.1186/1742-4690-7-90
work_keys_str_mv AT inagakinatsuko astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT takeuchihiroaki astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT yokoyamamasaru astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT satohironori astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT ryoakihide astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT yamamotohiroyuki astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT kawadamiki astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT matanotetsuro astructuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT inagakinatsuko structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT takeuchihiroaki structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT yokoyamamasaru structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT satohironori structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT ryoakihide structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT yamamotohiroyuki structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT kawadamiki structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins
AT matanotetsuro structuralconstraintforfunctionalinteractionbetweennterminalandcterminaldomainsinsimianimmunodeficiencyviruscapsidproteins